{{Rsnum
|rsid=9341266
|Gene=CYP1B1
|Chromosome=2
|position=38068851
|Orientation=minus
|GMAF=0.05188
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CYP1B1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 92.0 | 8.0 | 0.0
| HCB | 80.3 | 19.0 | 0.7
| JPT | 94.7 | 5.3 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 80.3 | 19.0 | 0.7
| CHD | 84.4 | 14.7 | 0.9
| GIH | 85.0 | 13.0 | 2.0
| LWK | 98.1 | 1.9 | 0.0
| MEX | 91.4 | 6.9 | 1.7
| MKK | 98.7 | 1.3 | 0.0
| TSI | 87.3 | 12.7 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19293312
|Title=Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women
|OA=1
}}

{{PMID Auto
|PMID=19015200
|Title=Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.
|OA=1
}}

{{PMID Auto
|PMID=19479063
|Title=Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}